Lung cancer screening: latest developments and unanswered questions

The Lancet Respiratory Medicine

Volumn 4, Issue 9, 2016, Pages 749-761

  van der Aalst, Carlijn M ^a   ten Haaf, Kevin ^a   de Koning, Harry J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; CANCER MORTALITY; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; DISTRESS SYNDROME; FALSE POSITIVE RESULT; HEALTH BEHAVIOR; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INCIDENTAL FINDING; LOW DOSE COMPUTED TOMOGRAPHY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; OVERDIAGNOSIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIATION HAZARD; RADIATION INDUCED NEOPLASM; REVIEW; SMOKING; SMOKING CESSATION PROGRAM; THORAX RADIOGRAPHY; UNNECESSARY PROCEDURE; AGED; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FEMALE; LUNG; LUNG TUMOR; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; TRENDS; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; RADIOGRAPHY, THORACIC; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84989817170     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30200-4     Document Type: Review

References (86)

1. 1 Ferlay, J, Soerjomataram, I, Dikshit, R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
2. 2 Siegel, RL, Miller, KD, Jemal, A, Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
3. 3 US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014, US Department for Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
4. 4 American Cancer Society. Cancer facts and figures 2010, 2010, American Cancer Society, Atlanta.
5. 5 Ten Haaf, K, van Rosmalen, J, de Koning, HJ, Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. Cancer Epidemiol Biomarkers Prev 24 (2015), 154–161.
6. 6 Oken, MM, Hocking, WG, Kvale, PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 306 (2011), 1865–1873.
7. 7 Henschke, CI, Yankelevitz, DF, Libby, DM, Pasmantier, MW, Smith, JP, Miettinen, OS, Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006), 1763–1771.
8. 8 Aberle, DR, Berg, CD, Black, WC, et al., for the National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 258 (2011), 243–253.
9. 9 Van Iersel, CA, De Koning, HJ, Draisma, G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120 (2007), 868–874.
10. 10 Pedersen, JH, Ashraf, H, Dirksen, A, et al. The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round. J Thorac Oncol 4 (2009), 608–614.
11. 11 Pastorino, U, Rossi, M, Rosato, V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21 (2012), 308–315.
12. 12 Field, JK, Devaraj, A, Baldwin, DR, et al. UK Lung Cancer Screening trial (UKLS): prevalence data at baseline. Lung Cancer 83 (2014), S24–S35.
13. 13 Becker, N, Delome, S, Kauczor, HU, LUSI: the German component of the European trial on the efficacy of multislice-CT for the early detection of lung cancer. Onkologie, 31(suppl 1), 2008, PO320 (abstr).
14. 14 Lopes Pegna, A, Picozzi, G, Mascalchi, M, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64 (2009), 34–40.
15. 15 Infante, M, Lutman, FR, Cavuto, S, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 59 (2008), 355–363.
16. 16 Patz, EF Jr, Greco, E, Gatsonis, C, Pinsky, P, Kramer, BS, Aberle, DR, Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 17 (2016), 590–599.
17. 17 Wille, MM, Dirksen, A, Ashraf, H, et al. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med 193 (2016), 542–551.
18. 18 Saghir, Z, Dirksen, A, Ashraf, H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67 (2012), 296–301.
19. 19 Infante, M, Cavuto, S, Lutman, FR, et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 191 (2015), 1166–1175.
20. 20 Humphrey, LL, Deffebach, M, Pappas, M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med 159 (2013), 411–420.
21. 21 Horeweg, N, van der Aalst, CM, Vliegenthart, R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 42 (2013), 1659–1667.
22. 22 Yousaf-Khan, U, van der Aalst, C, de Jong, PA, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5 years screening interval. Thorax, 2016, 10.1136/thoraxjnl-2016-208655 published online June 30.
23. 23 Becker, N, Motsch, E, Gross, ML, et al. Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization. J Thorac Oncol 10 (2015), 890–896.
24. 24 Lopes Pegna, A, Picozzi, G, Falaschi, F, et al. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol 8 (2013), 866–875.
25. 25 Field, JK, Duffy, SW, Baldwin, DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2016), 161–170.
26. 26 Aberle, DR, Adams, AM, Berg, CD, et al., for the National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
27. 27 Smith, RA, Manassaram-Baptiste, D, Brooks, D, et al. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin 65 (2015), 30–54.
28. 28 de Koning, HJ, Meza, R, Plevritis, SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force. Ann Intern Med 160 (2014), 311–320.
29. 29 Parker, MS, Groves, RC, Fowler, AA 3rd, et al. Lung cancer screening with low-dose computed tomography: an analysis of the MEDCAC decision. J Thorac Imaging 30 (2015), 15–23.
30. 30 Pinsky, PF, Gierada, DS, Hocking, W, Patz, EF Jr, Kramer, BS, National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 161 (2014), 627–633.
31. 31 Ma, J, Ward, EM, Smith, R, Jemal, A, Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 119 (2013), 1381–1385.
32. 32 Pinsky, PF, Church, TR, Izmirlian, G, Kramer, BS, The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 119 (2013), 3976–3983.
33. 33 van der Aalst, CM, van Iersel, CA, van Klaveren, RJ, et al. Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?. Lung Cancer 77 (2012), 51–57.
34. 34 Moyer, VA, on behalf of the US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160 (2014), 330–338.
35. 35 Howard, DH, Richards, TB, Bach, PB, Kegler, MC, Berg, CJ, Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. Cancer 121 (2015), 4341–4347.
36. 36 Raymakers, AJ, Mayo, J, Lam, S, FitzGerald, JM, Whitehurst, DG, Lynd, LD, Cost-effectiveness analyses of lung cancer screening strategies using low-dose computed tomography: a systematic review. Appl Health Econ Health Policy 14 (2016), 409–418.
37. 37 Puggina, A, Broumas, A, Ricciardi, W, Boccia, S, Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review. Eur J Public Health 26 (2016), 168–175.
38. 38 Black, WC, Gareen, IF, Soneji, SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 371 (2014), 1793–1802.
39. 39 Goffin, JR, Flanagan, WM, Miller, AB, et al. Cost-effectiveness of lung cancer screening in Canada. JAMA Oncol 1 (2015), 807–813.
40. 40 Tammemagi, MC, Application of risk prediction models to lung cancer screening: a review. J Thorac Imaging 30 (2015), 88–100.
41. 41 Bach, PB, Mirkin, JN, Oliver, TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307 (2012), 2418–2429.
42. 42 Huber, A, Landau, J, Ebner, L, et al. Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging. Eur Radiol, 2016, 10.1007/s00330-015-4192-3 published online Jan 26.
43. 43 Church, TR, Black, WC, Aberle, DR, et al., for the National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368 (2013), 1980–1991.
44. 44 Van der Aalst, CM, van Klaveren, RJ, van den Bergh, KA, Willemsen, MC, de Koning, HJ, The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J 37 (2011), 1466–1473.
45. 45 Pinsky, PF, Gierada, DS, Black, W, et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 162 (2015), 485–491.
46. 46 Baldwin, DR, Callister, ME, for the Guideline Development Group. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 70 (2015), 794–798.
47. 47 Ten Haaf, K, de Koning, HJ, Overdiagnosis in lung cancer screening: why modelling is essential. J Epidemiol Community Health 69 (2015), 1035–1039.
48. 48 Patz, EF Jr, Pinsky, P, Gatsonis, C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174 (2014), 269–274.
49. 49 Slatore, CG, Sullivan, DR, Pappas, M, Humphrey, LL, Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol 9 (2014), 927–934.
50. 50 Aggestrup, LM, Hestbech, MS, Siersma, V, Pedersen, JH, Brodersen, J, Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open, 2, 2012, e000663.
51. 51 Rasmussen, JF, Siersma, V, Pedersen, JH, Brodersen, J, Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer 87 (2015), 65–72.
52. 52 van den Bergh, KA, Essink-Bot, ML, Borsboom, GJ, Scholten, ET, van Klaveren, RJ, de Koning, HJ, Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 38 (2011), 154–161.
53. 53 Glanz, K, Rimer, BK, Lewis, FM, Health Behavior and Health Education. Theory, Research and Practice, 2002, Wiley & Sons, San Francisco.
54. 54 Pinsky, PF, Berg, CD, Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?. J Med Screen 19 (2012), 154–156.
55. 55 Ten Haaf, K, De Koning, HJ, Should never-smokers at increased risk for lung cancer be screened?. J Thorac Oncol 10 (2015), 1285–1291.
56. 56 Tammemagi, MC, Church, TR, Hocking, WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med, 11, 2014, e1001764.
57. 57 Tammemagi, MC, Katki, HA, Hocking, WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 368 (2013), 728–736.
58. 58 Kovalchik, SA, Tammemagi, M, Berg, CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 369 (2013), 245–254.
59. 59 Sverzellati, N, Silva, M, Calareso, G, et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol, 2016, 10.1007/s00330-016-4228-3 published online Feb 11.
60. 60 Horeweg, N, van Rosmalen, J, Heuvelmans, MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 15 (2014), 1332–1341.
61. 61 van Klaveren, RJ, Oudkerk, M, Prokop, M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 361 (2009), 2221–2229.
62. 62 McWilliams, A, Tammemagi, MC, Mayo, JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369 (2013), 910–919.
63. 63 Yip, R, Yankelevitz, DF, Henschke, CI, CT screening for lung cancer: definition of positive test result in the National Lung Screening Trial CT cohort compared with I-ELCAP. J Thorac Oncol, 8, 2013, S326.
64. 64 Gierada, DS, Pinsky, P, Nath, H, Chiles, C, Duan, F, Aberle, DR, Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst, 106, 2014, dju284.
65. 65 Slatore, CG, Baumann, C, Pappas, M, Humphrey, LL, Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the US Preventive Services Task Force. Ann Am Thorac Soc 11 (2014), 619–627.
66. 66 Tanner, NT, Kanodra, NM, Gebregziabher, M, et al. The association between smoking abstinence and mortality in the National Lung Screening Trial. Am J Respir Crit Care Med 193 (2016), 534–541.
67. 67 Tramontano, AC, Sheehan, DF, McMahon, PM, et al. Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: a simulation modelling study. BMJ Open, 6, 2016, e010227.
68. 68 Pua, BB, Dou, E, O'Connor, K, Crawford, CB, Integrating smoking cessation into lung cancer screening programs. Clin Imaging 40 (2016), 302–306.
69. 69 Marshall, HM, Courtney, DA, Passmore, LH, et al. Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial. Nicotine Tob Res 18 (2016), 1665–1669.
70. 70 Bade, M, Bahr, V, Brandt, U, et al. Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany. J Cancer Res Clin Oncol 142 (2016), 959–968.
71. 71 Pozzi, P, Munarini, E, Bravi, F, et al. A combined smoking cessation intervention within a lung cancer screening trial: a pilot observational study. Tumori 101 (2015), 306–311.
72. 72 Ashraf, H, Saghir, Z, Dirksen, A, et al. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax 69 (2014), 574–579.
73. 73 van der Aalst, CM, de Koning, HJ, van den Bergh, KA, Willemsen, MC, van Klaveren, RJ, The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer 76 (2012), 204–210.
74. 74 Lemmens, V, Oenema, A, Knut, IK, Brug, J, Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 17 (2008), 535–544.
75. 75 Fucito, LM, Czabafy, S, Hendricks, PS, et al. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 122 (2016), 1150–1159.
76. 76 Park, ER, Gareen, IF, Japuntich, S, et al. Primary care provider-delivered smoking cessation interventions and smoking cessation among participants in the National Lung Screening Trial. JAMA Intern Med 175 (2015), 1509–1516.
77. 77 Armaroli, P, Villain, P, Suonio, E, et al. European Code against Cancer, 4th edition: cancer screening. Cancer Epidemiol 39:suppl 1 (2015), S139–S152.
78. 78 van Hees, F, Zauber, AG, van Veldhuizen, H, et al. The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands. Gut 64 (2015), 1985–1997.
79. 79 McRonald, FE, Yadegarfar, G, Baldwin, DR, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 7 (2014), 362–371.
80. 80 Ali, N, Lifford, KJ, Carter, B, et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open, 5, 2015, e008254.
81. 81 Priola, AM, Priola, SM, Giaj-Levra, M, et al. Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. Clin Lung Cancer 14 (2013), 139–148.
82. 82 van de Wiel, JC, Wang, Y, Xu, DM, et al. Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 17 (2007), 1474–1482.
83. 83 Saghir Z, Dirksen A, Rasmussen JF, Heleno BM, Brodersen J, Pedersen JH. In lung cancer screening by CT incidental findings are frequent and often of clinical importance. American Thoracic Society 2012 International Conference; San Francisco, USA; May 18–May 23, 2012: abstr 5072.
84. 84 Watts, JR Jr, Sonavane, SK, Snell-Bergeon, J, Nath, H, Visual scoring of coronary artery calcification in lung cancer screening computed tomography: association with all-cause and cardiovascular mortality risk. Coron Artery Dis 26 (2015), 157–162.
85. 85 Mets, OM, Vliegenthart, R, Gondrie, MJ, et al. Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc Imaging 6 (2013), 899–907.
86. 86 Mets, OM, Buckens, CF, Zanen, P, et al. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 306 (2011), 1775–1781.